Venoms and Toxins 2020 Virtual Sole Sponsor
The Hamish Ogston Foundation (HOF) is a charitable foundation driven by a desire to contribute to lasting change, across three pillars: Health, Heritage and Music. Taking advantage of the commercial knowledge of its Founder, Hamish Ogston, and an experienced group of advisors, the Foundation introduces new disciplines and generates wider visions on impactful, fiscally prudent and longer-term giving.
The HOF is particularly committed to supporting and raising awareness of some lesser-known and preventable health issues, in particular snakebite. Having recognised the devastating impact snakebite can have, the Foundation aims to alleviate suffering by sponsoring high-quality antivenom research, and has recently committed to support research in three of the Asian countries worst affected by this neglected tropical disease. This will include hospital treatment of snakebite victims and first aid as well as support for studies into the effectiveness and safety of currently available and recently developed antivenoms.
Hamish Ogston CBE is an active philanthropist, supporting a range of initiatives related to health, heritage and music in and outside of the UK. Hamish was awarded his CBE in 2011 for services to business and the community in York.
The Journal (ISSN: 2044-0324) will publish high-quality peer-reviewed articles addressing most aspects of therapeutic, molecular, biochemical and evolutionary research on venoms, and envenomation. The Journal aims at providing an efficient route to fast-track publication, within 10-12 weeks of manuscript submission if accepted. Furthermore, manuscripts will be made available online in their final form generally within 2-3 weeks of final acceptance.
The Journal will be primarily published online but on sufficient demand for printed version journal hard copies may also be provided to individuals and institutions.
Manuscripts in the following categories will be considered for publication: reviews, mini-reviews, research articles, research reports, research letters, clinical reports, case studies, new methods and technologies, meeting reports and commercial, patent and product news and editorials.
The Journal is currently indexed in:
- PubMed Central
- PMC Canada
- The Directory of Open Access Journals
- Google Scholar
- OPEN J-Gate
- Chemical Abstracts Service (CAS)
- Academic Search Complete (EBSCO)